Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 10/20 | 0.62 |
| ▸ | SSTR1 | P30872 | 6/20 | 0.62 |
| ▸ | SSTR2 | P30874 | 6/20 | 0.62 |
| ▸ | SSTR3 | P32745 | 6/20 | 0.62 |
| ▸ | SSTR5 | P35346 | 6/20 | 0.62 |
| ▸ | TACR1 | P25103 | 2/20 | 0.53 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | CDC25B | P30305 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8577146 | 0.94 | SSTR4 (0.63) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL10781141 | 0.87 | SSTR1 (0.71) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL10781148 | 0.87 | SSTR1 (0.71) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL21148461 | 0.85 | SSTR1 (0.52) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL20019530 | 0.85 | SSTR1 (0.52) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL6890979 | 0.85 | SSTR1 (0.52) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL26273937 | 0.83 | SSTR1 (0.53) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL21080964 | 0.83 | SSTR1 (0.46) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL6229615 | 0.83 | SSTR4 (0.76) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL6545135 | 0.83 | SSTR1 (0.60) | SSTR4SSTR1SSTR2SSTR3SSTR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6908989-B2 | Process for the production of perbenzylated 1-O-glycosides | SCHERING AG (DE) | 2005-06-21 | — | — | US | disclosed |
| EP-1397376-B1 | METHOD FOR PRODUCING PERBENZYLATED 1-O-GLYCOSIDES | SCHERING AG (DE) | 2005-05-04 | — | — | EP | disclosed |
| EP-1404691-B1 | METHOD FOR PRODUCING PERACYLATED 1-O-GLYCOSIDES | SCHERING AG (DE) | 2005-03-09 | — | — | EP | disclosed |
| US-6831164-B2 | Generation of peracylated 1-O-glycosides; obtain chemical intermediate, react with alkylating agent, heat and recover product | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-12-14 | — | — | US | disclosed |
| EP-1397376-A1 | METHOD FOR PRODUCING PERBENZYLATED 1-O-GLYCOSIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-03-17 | — | — | EP | disclosed |
| EP-1261614-B1 | METHOD FOR THE PRODUCTION OF PERBENZYLATED 1-O GLYCOSIDES | SCHERING AG (DE) | 2004-01-07 | — | — | EP | disclosed |
| US-20030069402-A1 | Process for the production of peracylated 1-0-glycosides | SCHERING AG (DE) | 2003-04-10 | — | — | US | disclosed |
| US-6545135-B2 | Alkylation | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-04-08 | — | — | US | disclosed |
| US-20030055242-A1 | Process for the production of perbenzylated 1-O-glycosides | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2003-03-20 | — | — | US | disclosed |
| WO-2002102816-A1 | METHOD FOR PRODUCING PERBENZYLATED 1-O-GLYCOSIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-12-27 | — | — | WO | disclosed |
| US-20020002274-A1 | Process for the production of perbenzylated 1-0-glycosides | SCHERING AKTIENGESELLSCHAFT | 2002-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055242-A1 | Process for the production of perbenzylated 1-O-glycosides | MAN1B1, STT3B, OSTC | SSTR4 4291/4885SSTR1 4350/4885SSTR2 4469/4885 |
| US-20030069402-A1 | Process for the production of peracylated 1-0-glycosides | B3GNT2, UGT8, UGGT1 | SSTR4 4323/4885SSTR1 4101/4885SSTR2 4124/4885 |
| US-20020002274-A1 | Process for the production of perbenzylated 1-0-glycosides | STT3B, MAN1B1, OSTC | SSTR4 4009/4885SSTR1 4065/4885SSTR2 3996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.